Sign Up Today and Learn More About Omniscient Neurotechnology Stock
Invest in or calculate the value of your shares in Omniscient Neurotechnology or other pre-IPO companies through EquityZen's platform.
Omniscient Neurotechnology Stock (OMNE)
Omniscient develops AI and data-driven solutions to improve treatment for brain disorders, providing predictive analytics for clinicians.
About Omniscient Neurotechnology Stock
Founded
2019
Industries
Software, Artificial Intelligence, Data and Analytics
Omniscient Neurotechnology Press Mentions
Stay in the know about the latest news on Omniscient Neurotechnology
Processing of brain image data to assign voxels to parcellations
patents • Feb 08, 2025
Brain tractography by shading fiber bundles
patents • Feb 08, 2025
Automated machine learning systems and methods for mapping brain regions to …
patents • Feb 08, 2025
Dynamic model application based on subject characteristics
patents • Feb 08, 2025
Relative activation scores for brain parcels
patents • Feb 08, 2025
Omniscient Neurotechnology Management
Leadership team at Omniscient Neurotechnology
Chief Medical Officer & Director
Michael Sughrue
Chief Data Scientist & Director
Stephane Doyen
Join now and verify your accreditation status to gain access to:
- Omniscient Neurotechnology Current Valuation
- Omniscient Neurotechnology Stock Price
- Omniscient Neurotechnology Management
- Available deals in Omniscient Neurotechnology and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Omniscient Neurotechnology Cap Table and Funding History by Share Class and Liquidity Preferences
- Omniscient Neurotechnology Revenue and Financials
- Omniscient Neurotechnology Highlights
- Omniscient Neurotechnology Business Model
- Omniscient Neurotechnology Risk Factors
- Omniscient Neurotechnology Research Report from SACRA Research
Trading Omniscient Neurotechnology Stock
How to invest in Omniscient Neurotechnology stock?
Accredited investors can buy pre-IPO stock in companies like Omniscient Neurotechnology through EquityZen funds. These investments are made available by existing Omniscient Neurotechnology shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Omniscient Neurotechnology stock?
Shareholders can sell their Omniscient Neurotechnology stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
